%0 Journal Article
%T Development of chimeric antigen receptors targeting T-cell malignancies using two structurally different anti-CD5 antigen binding domains in NK and CRISPR-edited T cell lines
%A Andrew Fedanov
%A Christopher B. Doering
%A H. Trent Spencer
%A Kristopher A. Knight
%A Lauren C. Fleischer
%A Na Yoon Paik
%A Robert Moot
%A Sunil S. Raikar
%J Archive of "Oncoimmunology".
%D 2018
%R 10.1080/2162402X.2017.1407898
%K anti-cds scFv
%K chimeric antigen receptor
%K immunotheraphy
%K lamprey variable lymphocyte receptor
%K T-cell lenkemia
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790337/